IgE-话题@MedSci

#IgE#

86篇内容 | 2904人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1426329, encodeId=cc46142632938, content=<a href='/topic/show?id=032b948ec5' target=_blank style='color:#2F92EE;'>#IgE#</a>, objectTitle=Rigel治疗盘状红斑狼疮药物R333宣告失败, objectType=article, longId=26077, objectId=34f7260e798, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=34f7260e798, replyNumber=0, likeNumber=66, createdTime=2013-11-02, rootId=0, userName=zhenjiu124, userId=0cff4064659, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=34f7260e798, moduleTitle=Rigel治疗盘状红斑狼疮药物R333宣告失败, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=34f7260e798)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1426328, encodeId=c7ea1426328c5, content=<a href='/topic/show?id=032b948ec5' target=_blank style='color:#2F92EE;'>#IgE#</a>, objectTitle=Rigel制药放弃狼疮药R333临床开发, objectType=article, longId=25827, objectId=c7fd2582e4b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c7fd2582e4b, replyNumber=0, likeNumber=57, createdTime=2013-10-27, rootId=0, userName=zhenjiu124, userId=0cff4064659, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c7fd2582e4b, moduleTitle=Rigel制药放弃狼疮药R333临床开发, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c7fd2582e4b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1426327, encodeId=4fb8142632e1f, content=<a href='/topic/show?id=032b948ec5' target=_blank style='color:#2F92EE;'>#IgE#</a>, objectTitle=EMA授予OXiGENE公司ZYBRESTAT卵巢癌治疗孤儿药地位, objectType=article, longId=21909, objectId=09902190919, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=09902190919, replyNumber=0, likeNumber=67, createdTime=2013-07-25, rootId=0, userName=zhenjiu124, userId=0cff4064659, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=09902190919, moduleTitle=EMA授予OXiGENE公司ZYBRESTAT卵巢癌治疗孤儿药地位, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=09902190919)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1426326, encodeId=76251426326a1, content=<a href='/topic/show?id=032b948ec5' target=_blank style='color:#2F92EE;'>#IgE#</a>, objectTitle=Privigen能改善慢性炎症性脱髓鞘性多发性神经病患者的功能, objectType=article, longId=8061, objectId=a724806108, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a724806108, replyNumber=0, likeNumber=50, createdTime=2012-07-22, rootId=0, userName=zhenjiu124, userId=0cff4064659, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a724806108, moduleTitle=Privigen能改善慢性炎症性脱髓鞘性多发性神经病患者的功能, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a724806108)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1426325, encodeId=f2fa1426325d0, content=<a href='/topic/show?id=032b948ec5' target=_blank style='color:#2F92EE;'>#IgE#</a>, objectTitle=德国Medigene发布RhuDex临床配方试验积极性结果, objectType=article, longId=7316, objectId=51c0e3164b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=51c0e3164b, replyNumber=0, likeNumber=72, createdTime=2012-06-25, rootId=0, userName=zhenjiu124, userId=0cff4064659, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=51c0e3164b, moduleTitle=德国Medigene发布RhuDex临床配方试验积极性结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=51c0e3164b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1426324, encodeId=c5e914263247a, content=<a href='/topic/show?id=032b948ec5' target=_blank style='color:#2F92EE;'>#IgE#</a>, objectTitle=Digest Dis Sci：肠道细菌在肠易激综合征中发挥重要作用, objectType=article, longId=6677, objectId=7d1466e729, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7d1466e729, replyNumber=0, likeNumber=57, createdTime=2012-05-30, rootId=0, userName=zhenjiu124, userId=0cff4064659, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7d1466e729, moduleTitle=Digest Dis Sci：肠道细菌在肠易激综合征中发挥重要作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7d1466e729)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1426323, encodeId=3460142632352, content=<a href='/topic/show?id=032b948ec5' target=_blank style='color:#2F92EE;'>#IgE#</a>, objectTitle=特征因子(Eigenfactor)的背景及部分性质, objectType=article, longId=314, objectId=65c73148a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=65c73148a, replyNumber=0, likeNumber=0, createdTime=2010-06-20, rootId=0, userName=zhenjiu124, userId=0cff4064659, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=65c73148a, moduleTitle=特征因子(Eigenfactor)的背景及部分性质, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=65c73148a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1426322, encodeId=854514263224f, content=<a href='/topic/show?id=032b948ec5' target=_blank style='color:#2F92EE;'>#IgE#</a>, objectTitle=《期刊引用报告》(JCR)新增 EigenfactorTM Metrics(特征因子), objectType=article, longId=169, objectId=7387169d6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7387169d6, replyNumber=0, likeNumber=79, createdTime=2009-03-17, rootId=0, userName=zhenjiu124, userId=0cff4064659, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7387169d6, moduleTitle=《期刊引用报告》(JCR)新增 EigenfactorTM Metrics(特征因子), moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7387169d6)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

IgE

2020-05-29

zhenjiu124 (审核中...)

前往app查看评论内容

#IgE#

Rigel治疗盘状红斑狼疮药物R333宣告失败

2013-11-02

zhenjiu124 (审核中...)

前往app查看评论内容

#IgE#

Rigel制药放弃狼疮药R333临床开发

2013-10-27

zhenjiu124 (审核中...)

前往app查看评论内容

#IgE#

EMA授予OXiGENE公司ZYBRESTAT卵巢癌治疗孤儿药地位

2013-07-25

zhenjiu124 (审核中...)

前往app查看评论内容

#IgE#

Privigen能改善慢性炎症性脱髓鞘性多发性神经病患者的功能

2012-07-22

zhenjiu124 (审核中...)

前往app查看评论内容

#IgE#

德国Medigene发布RhuDex临床配方试验积极性结果

2012-06-25

zhenjiu124 (审核中...)

前往app查看评论内容

#IgE#

Digest Dis Sci：肠道细菌在肠易激综合征中发挥重要作用

2012-05-30

zhenjiu124 (审核中...)

前往app查看评论内容

#IgE#

特征因子(Eigenfactor)的背景及部分性质

2010-06-20

zhenjiu124 (审核中...)

前往app查看评论内容

#IgE#

《期刊引用报告》(JCR)新增 EigenfactorTM Metrics(特征因子)

2009-03-17

科室
- - 订阅+
  - 更多科室
工具
服务